Drugs / SUCLEAR®
last change Sep 2017 re-read 3 minutes ago

SUCLEAR®

Investigated by
Daehang Hospital · National Cancer Center, Korea

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) SUCLEAR — 2013-01-18 fda.gov ↗

Trials 1

today
US approved 2013
NCT02551198 · Ph 3
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02551198 Nov 2015 → Mar 2016 — National Cancer Center, Korea Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SUCLEAR ClinicalTrials.gov intervention name — accepted as the source's own label NCT02551198 ↗